RXRX

RXRX

USD

Recursion Pharmaceuticals Inc. Class A Common Stock

$5.000-0.200 (-3.846%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$5.200

高値

$5.320

安値

$4.970

出来高

57.15M

企業ファンダメンタルズ

時価総額

2.2B

業種

バイオテクノロジー

United States

取引統計

平均出来高

39.05M

取引所

NMS

通貨

USD

52週レンジ

安値 $3.79現在値 $5.000高値 $12.36

関連ニュース

GlobeNewswire

Recursion to Participate in Upcoming Investor Conferences

Salt Lake City, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today its participation in the following

もっと見る
Recursion to Participate in Upcoming Investor Conferences
GlobeNewswire

Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th

Salt Lake City, UT, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Recursion (NASDAQ:RXRX), a leading clinical stage TechBio company decoding biology to radically improve lives, announced today it will provide business updates and

もっと見る
Recursion to Report Third Quarter 2025 Business Updates and Financial Results on November 5th
Reuters

Buybacks take backseat as AI drives record US capex spending

Investors are increasingly favoring U.S. companies that channel capital toward AI innovation over those offering traditional shareholder payouts such as dividends and buybacks, even as the debate over soaring valuations and an AI bubble rages on.

もっと見る
Buybacks take backseat as AI drives record US capex spending